Biosimilar comparability is a structured scientific and regulatory process used to demonstrate that a biologic product is highly similar but not identical to an approved reference biologic, with no clinically meaningful differences in safety, purity, or potency
Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report
CrossRef Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019 Juhee Park, Kyeongjun Moon, Dong-Sook Kim Frontiers in Oncology.2022;[Epub] CrossRef Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea Diego Novick, Sae Young Lee, Dong Hyun Koo, Agota Szende, Sam Colman Journal of Drug Assessment.2022
There is also a pipeline of novel drug candidates, such as small-molecule, once-a-month injectable, and dual-triple GLP-1 agonists with the GIP and glucagon receptors
Appetite Suppression The medication significantly reduces hunger and food cravings
Depression or suicidal thoughts: Any noticeable changes in mood, behavior, or thoughtsespecially those that feel intense or unusualshould be shared with a healthcare provider right away